共 36 条
An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice
被引:26
作者:
Matoba, Tomoko
[2
]
Orba, Yasuko
[1
,2
]
Suzuki, Tadaki
[1
]
Makino, Yoshinori
[1
,4
]
Shichinohe, Hideo
[3
]
Kuroda, Satoshi
[3
]
Ochiya, Takahiro
[6
]
Itoh, Hiroshi
[7
]
Tanaka, Shinya
[2
]
Nagashima, Kazuo
[2
,5
]
Sawa, Hirofumi
[1
,4
]
机构:
[1] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Dept Mol Pathol, Sapporo, Hokkaido 00010020, Japan
[2] Hokkaido Univ, Grad Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido 060, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 060, Japan
[4] Hokkaido Univ, Century COE Program Zoonosis Control 21, Sapporo, Hokkaido 060, Japan
[5] Sapporo Higashi Tokushukai Hosp, Dept Pathol, Sapporo, Hokkaido, Japan
[6] Natl Canc Ctr, Sect Studies Metastasis, Tokyo, Japan
[7] Koken Co Ltd, Tokyo, Japan
关键词:
atelocollagen;
JC virus agnoprotein;
siRNA;
D O I:
10.1111/j.1440-1789.2007.00878.x
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
JC virus (JCV) is the etiological agent of the demyelinating disease progressive multifocal leukoencephalopathy (PML). Because JCV has a very narrow host range, it has been difficult to develop an animal model of JCV infection; as a result, no effective therapy for PML has been established. In this study, we have tried to create an animal model that replaces an in vivo JCV infection. As a result, we have obtained a stable persistence of JCV-infected human cells in the mouse brain by inoculating the virus-infected cells into the nude mice brains. In this model, the JCV-infected cells were well preserved in the nude mouse brains for 2 weeks. We then treated JCV-injected brains with an siRNA against the JCV agnoprotein that is known to be an effective inhibitor of JCV infection in vitro. A highly purified type I collagen, atelocollagen, was used as a carrier for the siRNA. The siRNA inhibited the expression of JCV protein in inoculated JCV-infected cells in the mouse brain, compared to the medium containing only atelocollagen used as a placebo. Thus, the combination of siRNA and atelocollagen might be a candidate therapeutic agent for the treatment of JCV infection.
引用
收藏
页码:286 / 294
页数:9
相关论文